Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.

× No keyword cloud information.

16 in total

1. PROTEIN-CARBOHYDRATE INTERACTION. II. INHIBITION STUDIES ON THE INTERACTION OF CONCANAVALIN A WITH POLYSACCHARIDES.

Authors: I J GOLDSTEIN; C E HOLLERMAN; E E SMITH
Journal: Biochemistry Date: 1965-05 Impact factor: 3.162

Review 2. The biological activities of soluble lymphocyte products.

Authors: E Pick; J L Turk
Journal: Clin Exp Immunol Date: 1972-01 Impact factor: 4.330

3. Macrophage-electrophoretic-mobility (M.E.M.) test for malignant disease. An independent confirmation.

Authors: J A Pritchard; J L Moore; W H Sutherland; C A Joslin
Journal: Lancet Date: 1972-09-23 Impact factor: 79.321

4. Cell migration inhibition factor released by antigen from human peripheral lymphocytes.

Authors: D E Thor; R E Jureziz; S R Veach; E Miller; S Dray
Journal: Nature Date: 1968-08-17 Impact factor: 49.962

5. Lymphocyte sensitisation: an in-vitro test for cancer?

Authors: E J Field; E A Caspary
Journal: Lancet Date: 1970-12-26 Impact factor: 79.321

6. Characterization of human migration inhibitory factor (MIF) from antigen-stimulated lymphocytes.

Authors: R E Rocklin; H G Remold; J R David
Journal: Cell Immunol Date: 1972-11 Impact factor: 4.868

7. Characterization of migration inhibitory factor (MIF) from guinea pig lymphocytes stimulated with concanavalin A.

Authors: H G Remold; R A David; J R David
Journal: J Immunol Date: 1972-09 Impact factor: 5.422

8. Specific lymphocyte sensitization in cancer: is there a common antigen in human malignant neoplasia?

Authors: E A Caspary; E J Field
Journal: Br Med J Date: 1971-06-12

9. Alterations of macrophage functions by mediators from lymphocytes.

Authors: C F Nathan; M L Karnovsky; J R David
Journal: J Exp Med Date: 1971-06-01 Impact factor: 14.307

10. Lymphocyte sensitization in advanced malignant disease: a study of serum lymphocyte depressive factor.

Authors: E J Field; E A Caspary
Journal: Br J Cancer Date: 1972-06 Impact factor: 7.640

17 in total

1. Distribution of electrophoretic mobilities of mouse thymocyte subpopulations in the presence of tumour cells.

Authors: R Jenkins
Journal: Immunology Date: 1975-11 Impact factor: 7.397

2. Scrapie: a review of its relation to human disease and ageing.

Authors: E J Field
Journal: J Med Genet Date: 1976-12 Impact factor: 6.318

3. Polymorphonuclear leukocyte function in ulcerative colitis and Crohn's disease.

Authors: A P Kirk; J Cason; J N Fordham; K A Brown; D H Goddard; E J Holborow; J E Lennard-Jones
Journal: Dig Dis Sci Date: 1983-03 Impact factor: 3.199

4. [The electrophoretic-mobility-(EM) test: a method for discrimination of malignant and non-malignant tumors (author's transl)].

Authors: C Tautz; W Schneider; E Laier; G Brügmann
Journal: Klin Wochenschr Date: 1978-02-15

5. Studies with the macrophage migration inhibition (MMI) test in patients with malignant disease.

Authors: P A Light; A W Preece; H A Waldron
Journal: Clin Exp Immunol Date: 1975-11 Impact factor: 4.330

6. Immunological cross-reactivity between basic proteins of myelin and cancer. I. Lymphocyte transformation studies in immunized guinea-pigs.

Authors: A S Coates; P R Carnegie
Journal: Clin Exp Immunol Date: 1975-10 Impact factor: 4.330

The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.